Top 19 Atara Biotherapeutics investors
The most complete profiles first. Showing 19 of 19.
Beth SeidenbergVerified
Venture Capital, Incubator, Investor · United States
Series BHealth CareGeneticsWomen FoundedLife SciencePortfolio: Atara Biotherapeutics, ACELYRIN, iPierian, Mango Health and 16 more
Verified email available
Brian HalakVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 61 more
Verified email available
Natalie JohnstonVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more
Verified email available
Owen SmithVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more
Verified email available
Eckard WeberVerified
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more
Verified email available
Jim BlairVerified
Venture Capital · United States
Health CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 53 more
Verified email available
John HannonVerified
Venture Capital, Private Equity Firm · United States
TelecommunicationsPaymentsSemantic SearchCybersecurityPortfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 65 more
Verified email available
Oleg NodelmanVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Sarah MarriottVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Scott PlatshonVerified
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Verified email available
Tom GoodrichVerified
Venture Capital · United States
PaymentsSemantic SearchCybersecurityDatabasesPortfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 62 more
Contact details available
Young ChungVerified
Venture Capital, Private Equity Firm · United States
PaymentsSemantic SearchCybersecurityDatabasesPortfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 61 more
Verified email available
Jesse Treu
Venture Capital, Founder, Investor · United States
SeedHealth CareWellnessWomen FoundedLife SciencePortfolio: Epic Sciences, Colorescience, Esperion Therapeutics, Astute Medical and 55 more
Contact details available
Kieran Mudryy
Venture Capital, Private Equity Firm, Investor · Singapore
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more
Contact details available
Caroline Stout
Venture Capital, Private Equity Firm · United States
Health CareInvestment ManagementAndroidLife SciencePortfolio: Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals, Eledon Pharmaceuticals and 53 more
Contact details available
Jonathan Kabakoff
Corporate Venture Capital · United States
Health CareWomen FoundedChemicalLife SciencePortfolio: Molecular Assemblies, Syros Pharmaceuticals, EpiBiome, Immunitas Therapeutics and 30 more
Contact details available
Joseph Zanone
Venture Capital, Private Equity Firm · United States
PaymentsSemantic SearchCybersecurityDatabasesPortfolio: Oportun, Harvest Power, Quantenna Communications, CardioDx and 61 more
Contact details available
Andrey Kozlov
Venture Capital · United Kingdom
Health CareGeneticsWomen FoundedLife SciencePortfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more
Contact details available
Vasily Fedorin
Venture Capital, Private Equity Firm · United Kingdom
Health CareGeneticsWomen FoundedInvestment ManagementPortfolio: Redpin Therapeutics, Atara Biotherapeutics, ADC Therapeutics, Orchard Therapeutics and 5 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Syndax Pharmaceuticals8
- Dicerna Pharmaceuticals8
- aTyr Pharma8
- Araris Biotech5
- ARMO BioSciences5
- Editas Medicine5
- SparingVision5
- Syros Pharmaceuticals5
- Relay Therapeutics5
- Autolus5
- Cellectis5
Frequently asked questions
How many Atara Biotherapeutics investors are on Angel Roster?
Angel Roster lists 19 Atara Biotherapeutics investors. 11 of them (58%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (18), Private Equity Firms (12) and Startup Incubators (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Atara Biotherapeutics investors invest in?
Among those that list a stage, the most common are Seed (5) and Series B (1).
Where are Atara Biotherapeutics investors based?
Most are based in the United States (14), the United Kingdom (4) and Singapore (1).
Which companies have Atara Biotherapeutics investors backed?
The most-backed portfolio companies among them are Syndax Pharmaceuticals (8), Dicerna Pharmaceuticals (8), aTyr Pharma (8), Araris Biotech (5) and ARMO BioSciences (5).
How do I contact Atara Biotherapeutics investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.